Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Cisplatin and Etoposide in NSCLC
NCT00003053Phase 3Unknown
- Sponsor
- European Institute of Oncology
- Start
- Jan 1994
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of cisplatin, etoposide in non-small cell lung cancer (NSCLC), sponsored by European Institute of Oncology. Status: unknown.
02
Drugs
cisplatinetoposide
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00003053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003053.